can inhibit SARS-CoV-2-induced hyper-inflammation and lung injury is highly significant, because it suggests an off-label use of MC stabilizers as immunomodulators to treat the severe cases of COVID-19.
← all excerpts
SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury.
1
—
—